Wall Street Zen is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category. The 49-day window averages about 0.4 stories each week.
Recent coverage · Susquehanna International Group LLP
↑
3stories
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Susquehanna International Group LLP
Wall Street Zen is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category. The 49-day window averages about 0.4 stories each week. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. This profile follows 3 Finance stories mentioning Susquehanna International Group LLP across the period from August 16, 2026 to October 3, 2026.
Stories tracked
3
Per week
0.4
Sources per story
2
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 764 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Susquehanna International Group LLP. Shared-story counts are live from our verified record — not editorial picks.
Scienture Holdings and Clearmind Medicine both execute reverse stock splits effective Oct. 5, 2026. SCNX's 1-for-25 split lifts its $0.18 stock to $4.50, while CMND's 1-for-8 split lifts $0.72 to $5.76, aiming to restore Nasdaq's $1 minimum bid.
BlackRock's commodity and energy closed-end funds are set to trade ex-distribution on November 13, locking in 6.5% and 6.6% yields. Institutional buyers have been accumulating both trusts, with UBS adding to BCX and several advisors initiating BGR positions. The simultaneous ex-date creates a point-in-time income event for yield-focused portfolios.
Lantern Pharma missed quarterly EPS estimates by $0.19, but shares rose 0.76% to $2.65 on double average volume. The micro-cap trades below both moving averages with a beta of 2.34 and a Sell consensus. Institutional accumulation is scattered and small.
Susquehanna International Group LLP is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.